The research in the group focuses on developing organoid and imaging technologies to improve disease modelling and drug testing.

Organoids are mini-organs – tiny, self-organised three-dimensional tissue cultures derived from stem cells or tumours. Their size, advanced differentiation, and potential human origin provide a convincing alternative to “classic” cell culture and animal models for preclinical drug testing and disease modelling. We primarily use imaging and biochemical analysis to compare development and responses of healthy and disease organoids.